{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:42:44Z","timestamp":1786549364807,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.neulet.2021.135975","type":"journal-article","created":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T00:09:54Z","timestamp":1621555794000},"page":"135975","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Cerebrospinal fluid levels of oxidative stress measured using diacron-reactive oxygen metabolites and biological antioxidant potential in patients with Parkinson\u2019s disease and progressive supranuclear palsy"],"prefix":"10.1016","volume":"757","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5971-9736","authenticated-orcid":false,"given":"Kenta","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Iwaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanako","family":"Yamahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2021.135975_bib0005","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.neulet.2021.135975_bib0010","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S1474-4422(17)30157-6","article-title":"New diagnostics and therapeutics for progressive supranuclear palsy","volume":"16","author":"Boxer","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neulet.2021.135975_bib0015","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1021\/tx960052v","article-title":"Synthesis, redox properties, in vivo formation, and neurobehavioral effects of N-acetylcysteinyl conjugates of dopamine: Possible metabolites of relevance to Parkinson\u2019s disease","volume":"9","author":"Shen","year":"1996","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.neulet.2021.135975_bib0020","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12264-007-0018-x","article-title":"Pathogenesis of Parkinson\u2019s disease: oxidative stress, environmental impact factors and inflammatory processes","volume":"23","author":"Yuan","year":"2007","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.neulet.2021.135975_bib0025","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3164\/jcbn.13-108","article-title":"Oxidized DJ-1 as a possible biomarker of Parkinson\u2019s disease","volume":"54","author":"Saito","year":"2014","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.neulet.2021.135975_bib0030","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/683920","article-title":"Neuroprotective function of DJ-1 in Parkinson\u2019s disease","volume":"2013","author":"Ariga","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neulet.2021.135975_bib0035","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9409363","article-title":"Glutathione as a biomarker in Parkinson\u2019s disease: associations with aging and disease severity","volume":"2016","author":"Mischley","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neulet.2021.135975_bib0040","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jns.2012.03.023","article-title":"Coenzyme Q10 deficiency in patients with Parkinson\u2019s disease","volume":"318","author":"Mischley","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neulet.2021.135975_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antiox9070597","article-title":"The role of oxidative stress in Parkinson\u2019s disease","volume":"9","author":"Chang","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.neulet.2021.135975_bib0050","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.redox.2016.04.003","article-title":"Imaging free radicals in organelles, cells, tissue, and in vivo with immuno-spin trapping","volume":"8","author":"Mason","year":"2016","journal-title":"Redox Biol."},{"key":"10.1016\/j.neulet.2021.135975_bib0055","series-title":"Annual Report of the Research Committee of CNS Degenerative Disease","first-page":"22","author":"Yanagisawa","year":"1996"},{"key":"10.1016\/j.neulet.2021.135975_bib0060","first-page":"189","article-title":"Consensus statement on the diagnosis of multiple system atrophy","volume":"74","author":"Gilman","year":"1998","journal-title":"J. Auton. Nerv. Syst."},{"key":"10.1016\/j.neulet.2021.135975_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2019.04.023","article-title":"Nanocatalysts-augmented Fenton chemical reaction for nanocatalytic tumor therapy","volume":"211","author":"Qian","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.neulet.2021.135975_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2020.12.035","article-title":"Alleviation of the chronic stress response attributed to the antioxidant and anti-inflammatory effects of electrolyzed hydrogen water","volume":"535","author":"Hu","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neulet.2021.135975_bib0075","first-page":"8","volume":"6","author":"Kitaoka","year":"2020","journal-title":"Health Care Sci."},{"key":"10.1016\/j.neulet.2021.135975_bib0080","series-title":"The Measurement of Oxidative Stress","first-page":"3","author":"Iorio","year":"2007"},{"key":"10.1016\/j.neulet.2021.135975_bib0085","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/mds.25383","article-title":"How to identify tremor dominant and postural instability\/gait difficulty groups with the movement disorder society unified Parkinson\u2019s disease rating scale: comparison with the unified Parkinson\u2019s disease rating scale","volume":"28","author":"Stebbins","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2021.135975_bib0090","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/jcla.20244","article-title":"Viral loads of cerebrospinal fluid in infants with enterovirus meningitis","volume":"22","author":"Kawashima","year":"2008","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.neulet.2021.135975_bib0095","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jns.2005.11.029","article-title":"Diagnostic and predictive value of CSF d-ROM level in influenza virus-associated encephalopathy","volume":"243","author":"Yamanaka","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neulet.2021.135975_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/brainsci10070466","article-title":"Cerebrospinal fluid biomarkers in Parkinson\u2019s disease: a critical overview of the literature and meta-analyses","volume":"10","author":"Katayama","year":"2020","journal-title":"Brain Sci."},{"key":"10.1016\/j.neulet.2021.135975_bib0105","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1468-1331.2006.01139.x","article-title":"Aging and oxidative stress in progressive supranuclear palsy","volume":"13","author":"Aoyama","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neulet.2021.135975_bib0110","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0006-8993(02)02244-8","article-title":"Expression and activity of antioxidants in the brain in progressive supranuclear palsy","volume":"930","author":"Cantuti-Castelvetri","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2021.135975_bib0115","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s11064-019-02910-5","article-title":"Pramipexole Inhibits MPP+-Induced Neurotoxicity by miR-494-3p\/BDNF","volume":"45","author":"Deng","year":"2020","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neulet.2021.135975_bib0120","doi-asserted-by":"crossref","first-page":"104608","DOI":"10.1016\/j.neuint.2019.104608","article-title":"Dopaminergic neuroprotective effects of rotigotine via 5-HT1A receptors: Possibly involvement of metallothionein expression in astrocytes","volume":"132","author":"Isooka","year":"2020","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neulet.2021.135975_bib0125","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.brainres.2013.12.030","article-title":"Rasagiline prevents neurodegeneration in thiamine deficient rats - A longitudinal MRI study","volume":"1557","author":"Dror","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2021.135975_bib0130","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00702-020-02150-w","article-title":"Rasagiline and selegiline modulate mitochondrial homeostasis, intervene apoptosis system and mitigate \u03b1-synuclein cytotoxicity in disease-modifying therapy for Parkinson\u2019s disease","volume":"127","author":"Naoi","year":"2020","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neulet.2021.135975_bib0135","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/ana.21885","article-title":"Neuroprotective effects of zonisamide target astrocyte","volume":"67","author":"Asanuma","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2021.135975_bib0140","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10571-012-9886-3","article-title":"Zonisamide attenuates MPP(+)-induced oxidative toxicity through modulation of Ca2+ signaling and caspase-3 activity in neuronal PC12 cells","volume":"33","author":"Y\u00fcrekli","year":"2013","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neulet.2021.135975_bib0145","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrn983","article-title":"Pathogenesis of Parkinson\u2019s disease: Dopamine, vesicles and \u03b1-synuclein","volume":"3","author":"Lotharius","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neulet.2021.135975_bib0150","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1750-3639.2007.00054.x","article-title":"Progressive supranuclear palsy: Pathology and genetics","volume":"17","author":"Dickson","year":"2007","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neulet.2021.135975_bib0155","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/brain\/114.4.1953","article-title":"Alterations in the levels of iron, ferritin and other trace metals in Parkinson\u2019s disease and other neurodegenerative diseases affecting basal ganglia","volume":"114","author":"Dexter","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.neulet.2021.135975_bib0160","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.biopsycho.2016.05.005","article-title":"A potential biomarker for fatigue: oxidative stress and anti-oxidative activity","volume":"118","author":"Fukuda","year":"2016","journal-title":"Biol. Psychol."},{"key":"10.1016\/j.neulet.2021.135975_bib0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046813","article-title":"Parkinson subtypes progress differently in clinical course and imaging pattern","volume":"7","author":"Eggers","year":"2012","journal-title":"PLoS One"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394021003530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394021003530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T20:40:29Z","timestamp":1759610429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394021003530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":33,"alternative-id":["S0304394021003530"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2021.135975","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebrospinal fluid levels of oxidative stress measured using diacron-reactive oxygen metabolites and biological antioxidant potential in patients with Parkinson\u2019s disease and progressive supranuclear palsy","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2021.135975","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"135975"}}